A Personalized Medicine Revolution
Prenosis leverages its ImmunixTM precision medicine platform to develop new precision medicine tools and to implement them in real time into workflow.
FDA De NovoAuthorized
The Sepsis ImmunoScore®, is the first-ever FDA authorized AI Diagnostic for Sepsis for the diagnosis of sepsis and the prediction of adverse outcomes.
Electronic Medical Records Integration
The Sepsis ImmunoScore® is available to integrate directly into hospital Electronic Medical Records. It’s also available via an exclusive partnership with Roche Diagnostics.
Biological Insights to Deliver the Right Precision Therapy.
Fast-moving acute care conditions pose a significant challenge for healthcare providers.
In modern hospital settings, providers still rely on symptom-based diagnoses rather than a patients’ unique biology. At Prenosis, our mission is to empower clinicians to see people differently by equipping them with a deep understanding of each patient’s biology. Using this understanding, clinicians can tailor treatments to individual needs and improve outcomes.
In modern hospital settings, providers still rely on symptom-based diagnoses rather than a patients’ unique biology. At Prenosis, our mission is to empower clinicians to see people differently by equipping them with a deep understanding of each patient’s biology. Using this understanding, clinicians can tailor treatments to individual needs and improve outcomes.
A cutting-edge artificial intelligence powered diagnostic, the Sepsis ImmunoScore is the first FDA authorized AI diagnostic for sepsis. By seamlessly integrating biomarkers and clinical data, our diagnostic presents real-time critical information, predicts future outcomes for patients, and expedites the delivery of optimal therapy. With direct integration into hospital Electronic Health Records, the Sepsis ImmunoScore enables timely interventions that improve patient outcomes, improve hospital quality metrics, and drive down hospital costs.
The World's Largest Biobank Linked to Clinical Data for Infection in Acute Care, built by the ImmunixTM precision medicine platform.
ImmunixTM simultaneously enables the development and validation of new precision medicine tools and the real-time implementation of those tools to improve patient care and outcomes.
10
Hospitals and Growing
100,000+
Longitudinal Specimens
25K+
Patients – Broad, Longitudinal Clinical Data
